Quantitative measurement of pioglitazone in neoplastic and normal tissues by AP-MALDI mass spectrometry imaging
Abstract
No abstract availableKeywords
Funding Information
- Fondazione Italiana per la Ricerca sul Cancro Airc (IG 23059)
- Associazione Italiana per la Ricerca sul Cancro
This publication has 57 references indexed in Scilit:
- Determination of Paclitaxel Distribution in Solid Tumors by Nano-Particle Assisted Laser Desorption Ionization Mass Spectrometry ImagingPLOS ONE, 2013
- Simultaneous determination of pioglitazone and candesartan in human plasma by LC-MS/MS and its application to a human pharmacokinetic studyJournal of Pharmaceutical Analysis, 2012
- Adipogenesis at a glanceJournal of Cell Science, 2011
- Fragmentation of toxicologically relevant drugs in positive‐ion liquid chromatography–tandem mass spectrometryMass Spectrometry Reviews, 2011
- Development and validation of an LC‐ESI‐MS/MS method for simultaneous quantitation of olmesartan and pioglitazone in rat plasma and its pharmacokinetic applicationBiomedical Chromatography, 2010
- Development of a high‐performance liquid chromatography method for simultaneous determination of pioglitazone and felodipine in pig serum: application to pharmacokinetic studyBiomedical Chromatography, 2010
- Novel Models of Myxoid Liposarcoma Xenografts Mimicking the Biological and Pharmacologic Features of Human TumorsClinical Cancer Research, 2010
- High-performance liquid chromatographic method for the determination of pioglitazone in human plasma using ultraviolet detection and its application to a pharmacokinetic studyJournal of Chromatography B, 2006
- A Phase II Study of Troglitazone, an Activator of the PPAR?? Receptor, in Patients with Chemotherapy-Resistant Metastatic Colorectal CancerThe Cancer Journal, 2002
- Stimulation of adipogenesis in fibroblasts by PPARγ2, a lipid-activated transcription factorCell, 1994